Banu Arslan Şentürk, Ruhan Uzun, Füsun Üstüner, Mustafa Cirit, Sadık İnce
Objective: Hyperphosphatemia and high calcium X phosphate product are significant and common risk factors of cardiovascular disease in patients with chronic kidney disease. However, the relationship is not clear between increased risk and hyperphosphatemia and elevated calcium...
Journal of Turkish Clinical Biochemistry
•
2006-04-01
İpek Ertorun, Gülşen Çiftçi Akalın, Özkan Alataş
Objective: Smoking is one of the most important cause of cardiovascular disease and known as a
preventable risk factor. Lipoproteins especially LDL has an important role in cardiovascular disease.
Normally high density lipoproteins protect LDL from oxidation; proinflammatory...
Journal of Turkish Clinical Biochemistry
•
2017-04-01
Semra Aksu Düzcü, Füsun Üstüner, Banu Arslan Şentürk, Serdar Deveci, Murat Yeşil
Objective: The prevalence of coronary artery disease is much higher in men than in women and sex hormones might play a role in these differences via their influence on lipid profile. However, the role of sex hormones in the relationship between male gender and cardiovascular...
Journal of Turkish Clinical Biochemistry
•
2010-12-01
Rabia Nur Kocabaş, A. Erkin Bozdemir, Güneş Başol, Burcu Barutçuoğlu, Zuhal Parıldar, Ceyda Kabaroğlu, Oya Bayındır
Objective: Cardiovascular diseases (CVD) are the leading causes of death worldwide. After understanding the importance of inflammation in the pathogenesis, CRP usage has been increased for the determination of cardiovascular risk. As an inflammation marker, the relationship...
Journal of Turkish Clinical Biochemistry
•
2007-08-01
Okan Dikker, Mustafa Şahin
Aim: Lipid profile is used to determine the risk of cardiovascular diseases (CVD) and to monitor
treatment. Reference change value (RCV) represents the clinical significance of the variation between the
results of two consecutive tests and laboratory test results exceeding...
Journal of Turkish Clinical Biochemistry
•
2019-08-01
Özben Özden Işıklar, Güneş Başol, Burcu Barutçuoğlu, Erkin Bozdemir, Ceyda Kabaroğlu, Zuhal Parıldar, Işıl Mutaf, Dilek Özmen
Objective: After proving that chronic low grade inflammation is an important component of atherosclerotic process, C-reactive protein (CRP) has been started to be used for atherosclerotic vascular disease risk determination together with the other risk factors. In practice, to...
Journal of Turkish Clinical Biochemistry
•
2007-04-01
Ceyda Kabaroğlu, Kenan Aksu, Gökhan Keser, Fahrettin Oksel, Işıl Mutaf, Sara Habif
Aim: Raynaud's phenomenon is characterized by transient reduction in blood supply through the small arteries in the hands and feet. Secondary Raynaud's phenomenon accompanies collagen vascular diseases such as rheumatoid arthritis and scleroderma. The relationship between...
Journal of Turkish Clinical Biochemistry
•
2004-04-01
Selda Demirtaş, Gökhan Nergizoğlu, Levent Karaca
In chronic renal failure, high plasma homocysteine levels are a common finding and in uremia almost the rule. The cause of hyperhomocysteinemia in ESRD (end stage renal disease) whether it lies in an impared renal or extrarenal metabolism or through uremic retention toxins, is still under...
Journal of Turkish Clinical Biochemistry
•
2003-04-01
Hüseyin Kurku, İbrahim Solak, Yavuz Turgut Gederet, Mehmet Ali Eryilmaz
Aim: Smoking is accepted as a risk factor for primary chronic diseases such as cardiovascular diseases
and respiratory system diseases and for cancer development. The aim of this study was to indicate the
increase in inflammation in smokers by using high-sensitivity...
Journal of Turkish Clinical Biochemistry
•
2021-04-01
Bilge Karatoy Erdem, Halide Akbas
Patients with chronic kidney disease (CKD) have a high risk of cardiovascular morbidity and mortality.
Vascular calcification (VC) is the most important cause of cardiovascular morbidity and mortality both in
the general population and CKD. VC is mainly associated with mineral metabolism and...
Journal of Turkish Clinical Biochemistry
•
2017-08-01
Ahmet Solak, Pınar Tuncel
Objective: Metabolic syndrome is a comorbidity of insulin resistance, impaired glucose tolerance,
abdominal obesity, hypertension and dyslipidemia and associated with increased risk of cardiovascular
disease. The secretion of adipocytokines such as leptin and adiponectin...
Journal of Turkish Clinical Biochemistry
•
2009-04-01